Publicaciones en las que colabora con Nuria Paricio (13)

2024

  1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

2023

  1. Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson’s Disease Based on DJ-1 Deficiency

    ACS Chemical Neuroscience, Vol. 14, Núm. 12, pp. 2294-2301

  2. Evaluation of type 1 diabetes mellitus as a risk factor of Parkinson's disease in a Drosophila model

    Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, Vol. 339, Núm. 8, pp. 697-705

2022

  1. Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases

    Antioxidants, Vol. 11, Núm. 5

  2. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 36, Núm. 8, pp. e22432

  3. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

  4. Modeling of Parkinson’s disease in Drosophila based on DJ-1 deficiency

    Handbook of Animal Models in Neurological Disorders (Elsevier), pp. 467-480

2021

  1. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment

    Neurotherapeutics, Vol. 18, Núm. 4, pp. 2565-2578

  2. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 7

2020

  1. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency

    Free Radical Biology and Medicine, Vol. 158, pp. 137-148

2019

  1. Drosophila as a model system for the identification of pharmacological therapies in neurodegenerative diseases

    Insights into Human Neurodegeneration: Lessons Learnt from Drosophila (Springer Singapore), pp. 433-467

2018

  1. Cbt modulates Foxo activation by positively regulating insulin signaling in Drosophila embryos

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1861, Núm. 9, pp. 878-891

2017

  1. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models

    Free Radical Biology and Medicine, Vol. 108, pp. 683-691